FDA Removes Boxed Warnings from 2 Quit-Smoking Medications
The FDA has removed the boxed warning regarding serious neuropsychiatric events from two stop-smoking medicines, varenicline (Chantix) and bupropion (Zyban). Based on a review of a large clinical trial, FDA has determined the risk of serious side effects on mood, behavior, or thinking is lower than previously suspected. The risk of these mental health side effects is still …